Overview
Yusuke Kanemasa practices in Tokyo, Japan. Mr. Kanemasa is rated as an Experienced expert by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neurotoxicity Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaMr. Kanemasa isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Kanemasa isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Advanced
- Non-Hodgkin LymphomaMr. Kanemasa isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Bone Marrow AspirationMr. Kanemasa isExperienced. Learn about Bone Marrow Aspiration.
- ChoriocarcinomaMr. Kanemasa isExperienced. Learn about Choriocarcinoma.
- Follicular LymphomaMr. Kanemasa isExperienced. Learn about Follicular Lymphoma.
- Lung MetastasesMr. Kanemasa isExperienced. Learn about Lung Metastases.
- Neurotoxicity SyndromesMr. Kanemasa isExperienced. Learn about Neurotoxicity Syndromes.
- Peripheral T-Cell LymphomaMr. Kanemasa isExperienced. Learn about Peripheral T-Cell Lymphoma.